Currently, there are 209.76M common shares owned by the public and among those 199.97M shares have been available to trade.
The company’s stock has a 5-day price change of 12.75% and -25.44% over the past three months. COIN shares are trading -17.75% year to date (YTD), with the 12-month market performance down to -22.05% lower. It has a 12-month low price of $146.12 and touched a high of $349.75 over the same period. COIN has an average intraday trading volume of 9.08 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 2.63%, -16.30%, and -12.43% respectively.
Institutional ownership of Coinbase Global Inc (NASDAQ: COIN) shares accounts for 45.88% of the company’s 209.76M shares outstanding.
It has a market capitalization of $51.85B and a beta (3y monthly) value of 3.64. The stock’s trailing 12-month PE ratio is 21.52, while the earnings-per-share (ttm) stands at $9.49. The company has a debt-to-equity ratio at 0.45. Price movements for the stock have been influenced by the stock’s volatility, which stands at 4.60% over the week and 7.35% over the month.
Analysts forecast that Coinbase Global Inc (COIN) will achieve an EPS of 2.29 for the current quarter, 1.77 for the next quarter and 8.23 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 1.71 while analysts give the company a high EPS estimate of 1.71. Comparatively, EPS for the current quarter was 4.4 a year ago. Earnings per share for the fiscal year are expected to decrease by -18.19%, and 9.22% over the next financial year.
Looking at the support for the COIN, a number of firms have released research notes about the stock. Goldman stated their Neutral rating for the stock in a research note on March 20, 2025, with the firm’s price target at $195. Bernstein coverage for the Coinbase Global Inc (COIN) stock in a research note released on March 18, 2025 offered a Outperform rating with a price target of $310. Rosenblatt was of a view on March 07, 2025 that the stock is Buy, while Mizuho gave the stock Outperform rating on January 29, 2025, issuing a price target of $250- $290. Monness Crespi & Hardt on their part issued Buy rating on December 19, 2024.
